PeriRx, LLC Covering All Bases During Its Greater New York Dental Meeting Debut

"We're very excited to be making our official debut at the Greater New York Dental Meeting," said Stephen M. Swanick, CEO and founder of PeriRx, LLC. "We're using a variety of ways to engage with members of the dental community and tell them about SaliMarkATM OSCC, the most clinically-advanced salivary test for oral cancer, which is scheduled to ship before the end of the year." Development of this simple-to-use, painless and accurate test was based on the strong scientific foundation of NIH-funded research with initial discovery and pre-validation work conducted by Dr. David Wong of the University of California at Los Angeles.

http://ift.tt/14YCcDr